Bonesupport Holding AB (publ) (LON: 0RQO)
London
· Delayed Price · Currency is GBP · Price in SEK
374.36
-1.84 (-0.49%)
At close: Jan 22, 2025
Bonesupport Holding AB Revenue
Bonesupport Holding AB had revenue of 237.50M SEK in the quarter ending September 30, 2024, with 50.12% growth. This brings the company's revenue in the last twelve months to 814.46M, up 56.16% year-over-year. In the year 2023, Bonesupport Holding AB had annual revenue of 591.08M with 79.76% growth.
Revenue (ttm)
814.46M SEK
Revenue Growth
+56.16%
P/S Ratio
n/a
Revenue / Employee
6.90M SEK
Employees
118
Market Cap
1.81B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 591.08M | 262.26M | 79.76% |
Dec 31, 2022 | 328.82M | 115.93M | 54.46% |
Dec 31, 2021 | 212.89M | 32.03M | 17.71% |
Dec 31, 2020 | 180.86M | 25.40M | 16.34% |
Dec 31, 2019 | 155.46M | 58.84M | 60.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |